PERKINS CAPITAL MANAGEMENT INC - Q2 2024 holdings

Add to watchlist

$106 Million is the total value of PERKINS CAPITAL MANAGEMENT INC's 88 reported holdings in Q2 2024. The portfolio turnover from Q1 2024 to Q2 2024 was 0.0% .

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
IDXX  IDEXX LABS INC$5,116
-9.8%
10,5000.0%4.82%
+2.0%
AMD  ADVANCED MICRO DEVICES INC$3,658
-10.1%
22,5540.0%3.45%
+1.5%
VCEL  VERICEL CORP$1,434
-11.8%
31,2500.0%1.35%
-0.4%
AAPL  APPLE INC$979
+22.8%
4,6500.0%0.92%
+38.6%
COP  CONOCOPHILLIPS$915
-10.1%
8,0000.0%0.86%
+1.5%
CIEN  CIENA CORP$807
-2.5%
16,7500.0%0.76%
+10.1%
BAX  BAXTER INTL INC$686
-21.8%
20,5090.0%0.65%
-11.6%
NXPI  NXP SEMICONDUCTORS N V$659
+8.6%
2,4500.0%0.62%
+22.7%
 BACKBLAZE INC$658
-39.8%
106,8350.0%0.62%
-31.9%
DCI  DONALDSON INC$636
-4.1%
8,8840.0%0.60%
+8.3%
ANIP  ANI PHARMACEUTICALS INC$585
-7.9%
9,1910.0%0.55%
+4.0%
CDXS  CODEXIS INC$495
-11.1%
159,6000.0%0.47%
+0.4%
LFVN  LIFEVANTAGE CORP$489
+6.3%
76,1130.0%0.46%
+20.1%
BP  BP PLCsponsored adr$374
-4.1%
10,3500.0%0.35%
+8.3%
JNJ  JOHNSON & JOHNSON$329
-7.6%
2,2500.0%0.31%
+4.4%
OPCH  OPTION CARE HEALTH INC$305
-17.3%
11,0000.0%0.29%
-6.8%
BLFS  BIOLIFE SOLUTIONS INC$289
+15.6%
13,5000.0%0.27%
+30.8%
IONS  IONIS PHARMACEUTICALS INC$265
+10.0%
5,5500.0%0.25%
+24.4%
LTRX  LANTRONIX INC$1470.0%41,4000.0%0.14%
+13.0%
 JOURNEY MED CORP$124
+53.1%
22,0000.0%0.12%
+72.1%
NMTC  NEUROONE MED TECHNOLOGIES CO$120
-33.3%
150,0000.0%0.11%
-24.7%
 SHIMMICK CORPORATION$80
-73.2%
51,9000.0%0.08%
-69.9%
CYRX  CRYOPORT INC$79
-61.3%
11,5000.0%0.07%
-56.5%
DYAI  DYADIC INTL INC DEL$71
-11.2%
47,8500.0%0.07%0.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2024-08-09
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NEOGENOMICS INC44Q2 20247.8%
LILY ELI & CO44Q2 202410.8%
PFIZER INC44Q2 20242.9%
ATTUNITY LTD44Q2 20243.6%
EXPEDITORS INTL WASH INC44Q2 20242.3%
CVS HEALTH CORP44Q2 20241.6%
DONALDSON INC44Q2 20241.3%
VERIZON COMMUNICATIONS INC44Q2 20241.0%
US BANCORP DEL44Q2 20240.8%
BAXTER INTL INC43Q2 202414.1%

View PERKINS CAPITAL MANAGEMENT INC's complete holdings history.

Latest significant ownerships (13-D/G)
PERKINS CAPITAL MANAGEMENT INC Q2 2024 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
BIOLASE, INCMay 15, 2023689,1962.1%
FlexShopper, Inc.February 09, 20231,281,4605.9%
Avinger IncFebruary 14, 2020891,7615.2%
Black Ridge Oil & Gas, Inc.February 15, 201930,021,0326.3%
CANCER GENETICS, INCFebruary 15, 20191,135,2504.0%
TearLab CorpFebruary 15, 20191,666,29413.1%
Xtant Medical Holdings, Inc.February 15, 2019684,4083.6%
TearLab CorpJanuary 26, 20184,300,65540.1%
BIO KEY INTERNATIONAL INCFebruary 09, 2017274,9004.4%
EnteroMedics IncFebruary 09, 20171,4550.0%

View PERKINS CAPITAL MANAGEMENT INC's complete significant-ownership history.

Latest filings
TypeFiled
N-PX2024-08-28
13F-HR2024-08-09
13F-HR2024-05-09
13F-HR2024-01-22
13F-HR2023-11-02
13F-HR2023-07-21
SC 13G/A2023-05-15
13F-HR2023-05-09
SC 13G/A2023-02-09
SC 13G2023-02-09

View PERKINS CAPITAL MANAGEMENT INC's complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (106132000.0 != 106132.0)

Export PERKINS CAPITAL MANAGEMENT INC's holdings

CSVXLS